Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolandi Swart

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Genetics and Genomics : MGG|May 23, 2020
Prospective avenues for human population genomics and disease mapping in southern AfricaYolandi Swart, Gerald van Eeden, Anel Sparks, et al.
Frontiers in Genetics|November 1, 2021
Local Ancestry Adjusted Allelic Association Analysis Robustly Captures Tuberculosis Susceptibility LociYolandi Swart, Caitlin Uren, Paul D van Helden, et al.
Current Protocols|June 5, 2024
Data Harmonization Guidelines to Combine Multi-platform Genomic Data from Admixed Populations and Boost Power in Genome-Wide Association StudiesDayna Croock, Yolandi Swart, Haiko Schurz, et al.
Human Genetics|October 19, 2024
Methodologies underpinning polygenic risk scores estimation: a comprehensive overviewCarene Anne Alene Ndong Sima, Kathryn Step, Yolandi Swart, et al.
Plos One|September 28, 2022
GWAS in the southern African contextYolandi Swart, Gerald van Eeden, Caitlin Uren, et al.
Tuberculosis (Edinburgh, Scotland)|May 12, 2025
Uncharted territory: the role of mitochondrial DNA variation in macrophage-mediated host susceptibility to tuberculosisDayna Croock, Yolandi Swart, Tomasz Janusz Sanko, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Genome-wide association analyses reveal susceptibility variants linked to Parkinson's disease in the South African population using inferred global and local ancestryKathryn Step, Thiago Peixoto Leal, Emily Waldo, et al.
The Lancet. Infectious Diseases|August 24, 2023
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trialBruno Maranda, Sébastien M Labbé, Magali Lurquin, et al.
Frontiers in Genetics|April 7, 2025
Assessment of physician preparedness for implementation of pathology-supported genetic testing: solution-driven post-COVID-19 surveyElouise E Kroon, Yolandi Swart, Chantelle J Scott, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Genetics and Genomics : MGG|May 23, 2020
Prospective avenues for human population genomics and disease mapping in southern AfricaYolandi Swart, Gerald van Eeden, Anel Sparks, et al.
Frontiers in Genetics|November 1, 2021
Local Ancestry Adjusted Allelic Association Analysis Robustly Captures Tuberculosis Susceptibility LociYolandi Swart, Caitlin Uren, Paul D van Helden, et al.
Current Protocols|June 5, 2024
Data Harmonization Guidelines to Combine Multi-platform Genomic Data from Admixed Populations and Boost Power in Genome-Wide Association StudiesDayna Croock, Yolandi Swart, Haiko Schurz, et al.
Human Genetics|October 19, 2024
Methodologies underpinning polygenic risk scores estimation: a comprehensive overviewCarene Anne Alene Ndong Sima, Kathryn Step, Yolandi Swart, et al.
Plos One|September 28, 2022
GWAS in the southern African contextYolandi Swart, Gerald van Eeden, Caitlin Uren, et al.
Tuberculosis (Edinburgh, Scotland)|May 12, 2025
Uncharted territory: the role of mitochondrial DNA variation in macrophage-mediated host susceptibility to tuberculosisDayna Croock, Yolandi Swart, Tomasz Janusz Sanko, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Genome-wide association analyses reveal susceptibility variants linked to Parkinson's disease in the South African population using inferred global and local ancestryKathryn Step, Thiago Peixoto Leal, Emily Waldo, et al.
The Lancet. Infectious Diseases|August 24, 2023
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trialBruno Maranda, Sébastien M Labbé, Magali Lurquin, et al.
Frontiers in Genetics|April 7, 2025
Assessment of physician preparedness for implementation of pathology-supported genetic testing: solution-driven post-COVID-19 surveyElouise E Kroon, Yolandi Swart, Chantelle J Scott, et al.
Pageof 1